Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-02-19

Clinical Trial Update: A Novel Mutation of the Spectrin Gene

View source ↗

Summary

A completed clinical trial identified a novel mutation in the spectrin gene associated with hereditary elliptocytosis and hereditary pyropoikilocytosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Utah | Conditions: Hereditary Elliptocytosis (HE), Hereditary Pyropoikilocytosis (HPP) | Status: COMPLETED